Maccura Biotechnology extends controlling shareholder agreement

Maccura Biotechnology (SZSE:300463) announced that its controlling shareholders, Tang Yong, Wang Dengming, and Liu Qilin, have renewed their concerted action agreement until March 27, 2028. This extends the original agreement, set to expire on March 27, 2025, for an additional three years. The shareholders collectively hold 24.1119% of the company's shares, totaling 146,724,156 shares. Maccura stated the extension aims to maintain consistent management and strategic direction, thus promoting the company's long-term interests and stability. The company has 608,511,590 shares outstanding (excluding shares held in a repurchase account).